132370-95-7

Basic information

• Product Name: (2,6-Diethylphenyl)hydrazine hydrochloride
• Synonyms: 1-(2,6-Diethylphenyl)hydrazine, HCl;Hydrazine, (2,6-diethylphenyl)-, hydrochloride (1:1)
• CAS NO: 132370-95-7
• Molecular Formula: C₁₀H₁₆N₂*ClH
• Molecular Weight: 200.70838
• Mol File: 132370-95-7.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (2,6-Diethylphenyl)hydrazine hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: (2,6-Diethylphenyl)hydrazine hydrochloride(132370-95-7)
• EPA Substance Registry System: (2,6-Diethylphenyl)hydrazine hydrochloride(132370-95-7)

Safety Data

• Hazardous Substances Data: 132370-95-7(Hazardous Substances Data)

Usage

General Description

(2,6-Diethylphenyl)hydrazine hydrochloride is a chemical compound that is used in biological research and pharmaceutical development. It is a hydrazine derivative that is typically used as an intermediate in the synthesis of organic compounds. (2,6-Diethylphenyl)hydrazine hydrochloride is known to have potential anti-tumor and anti-bacterial properties, making it an area of interest in medicinal chemistry. (2,6-Diethylphenyl)hydrazine hydrochloride is also used as a reagent in the synthesis of various organic compounds, and it has the potential to be used in the development of new drugs for the treatment of cancer and infectious diseases. Overall, (2,6-Diethylphenyl)hydrazine hydrochloride is an important chemical compound with potential applications in both research and pharmaceutical industries.

Upstream product

• 1447813-80-0 di-tert-butyl 1-(2,6-diethylphenyl)hydrazine-1,2-dicarboxylate 
• 579-66-8 2,6-diethylaniline 

Downstream Products

• 1447823-12-2 (S,Z)-2-benzhydryl-5-(2-(2,6-diethylphenyl)hydrazono)pyrrolidine hydrochloride 
• 1616514-84-1 1-(2,6-diethylphenyl)-2-(4-nitrophenyl)diazene 
• 579-66-8 2,6-diethylaniline 

Relevant articles and documents

DIARYL SUBSTITUTED 5,5-FUSED RING COMPOUNDS AS C5aR INHIBITORS

The present disclosure provides, inter alia, Compounds of Formula (I) or pharmaceutically acceptable salts thereof that are modulators of the C5a receptor. Also provided are pharmaceutical compositions and methods of use including the treatment of diseases or disorders involving pathologic activation from C5a and non-pharmaceutical applications.

PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS

The present disclosure provides, inter alia, Compounds of Formulae IA, IB, IC, IIA, IIB and IIC or pharmaceutically acceptable salts thereof that are modulators of the C5a receptor. Also provided are pharmaceutical compositions and methods of use including the treatment of diseases or disorders involving pathologic activation from C5a and non-pharmaceutical applications.

6-5 FUSED RINGS AS C5a INHIBITORS

The present disclosure provides, inter alia, Compounds of Formula (I) (I) or pharmaceutically acceptable salts thereof that are modulators of the C5a receptor. Also provided are pharmaceutical compositions and methods of use including the treatment of diseases or disorders involving pathologic activation from C5a and non-pharmaceutical applications.